Compare NSYS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSYS | NEPH |
|---|---|---|
| Founded | 1981 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 40.1M |
| IPO Year | 1996 | 2004 |
| Metric | NSYS | NEPH |
|---|---|---|
| Price | $16.07 | $3.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 15.6K | 8.6K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.85 | ★ 1000.00 |
| EPS | N/A | ★ 0.01 |
| Revenue | $14,371,000.00 | ★ $18,789,000.00 |
| Revenue This Year | N/A | $11.24 |
| Revenue Next Year | N/A | $11.58 |
| P/E Ratio | ★ N/A | $337.00 |
| Revenue Growth | 7.01 | ★ 32.67 |
| 52 Week Low | $6.50 | $2.66 |
| 52 Week High | $18.01 | $6.42 |
| Indicator | NSYS | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 61.76 |
| Support Level | $15.50 | $3.66 |
| Resistance Level | $17.79 | $3.79 |
| Average True Range (ATR) | 0.88 | 0.21 |
| MACD | -0.19 | 0.04 |
| Stochastic Oscillator | 28.57 | 94.62 |
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.